Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare form of primary liver cancer composed of cells with histopathologic features of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Because of its low incidence, the information on clinical outcomes of cHCC-CC is very limited and there are no published reports describing non-surgical treatment options for cHCC-CC. We report a case of cHCC-CC exhibiting a favorable response to systemic chemotherapy with doxorubicin and cisplatin. A 62-year-old man who recurred after a right lobectomy for cHCC-CC received sorafenib for palliative systemic therapy, but follow up imaging studies showed disease progression. He received 2nd line chemotherapy with doxorubicin at 60 mg/m² together with cisplatin at 70 mg/m². After 2 cycles of chemotherapy, a computed tomography scan of the chest showed markedly decreased size and number of the multiple lung metastases. After completing 8 cycles of 2nd line therapy, we changed the regimen to a fluorouracil (5-FU) mono therapy because of the toxicities associated with doxorubicin and cisplatin. To date, the patient has completed his 15th cycle of 5-FU mono therapy with the disease status remaining stable during 18 months of follow-up.

Citations

Citations to this article as recorded by  

• Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
  Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter
  Liver Cancer.2024; 13(1): 6.     CrossRef
• A New Scoring Method for Personalized Prognostic Prediction in Patients with Combined Hepatocellular and Cholangiocarcinoma After Surgery
  Feng Zhang, Keshu Hu, Bei Tang, Mengxin Tian, Shenxin Lu, Jia Yuan, Miao Li, Rongxin Chen, Zhenggang Ren, Yinghong Shi, Xin Yin
  Journal of Gastrointestinal Surgery.2021; 25(4): 971.     CrossRef
• Treatment of Combined Hepatocellular and Cholangiocarcinoma
  Simona Leoni, Vito Sansone, Stefania De Lorenzo, Luca Ielasi, Francesco Tovoli, Matteo Renzulli, Rita Golfieri, Daniele Spinelli, Fabio Piscaglia
  Cancers.2020; 12(4): 794.     CrossRef
• Therapy of Primary Liver Cancer
  Mei Feng, Yisheng Pan, Ruirui Kong, Shaokun Shu
  The Innovation.2020; 1(2): 100032.     CrossRef
• Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature
  Yuka Futsukaichi, Kazuto Tajiri, Saito Kobayashi, Kohei Nagata, Satoshi Yasumura, Terumi Takahara, Masami Minemura, Ichiro Yasuda
  Clinical Journal of Gastroenterology.2019; 12(2): 128.     CrossRef
• Clinical and pathological features of combined hepatocellular–cholangiocarcinoma compared with other liver cancers
  Kazuki Wakizaka, Hideki Yokoo, Toshiya Kamiyama, Masafumi Ohira, Koichi Kato, Yuki Fujii, Ko Sugiyama, Naoki Okada, Takanori Ohata, Akihisa Nagatsu, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Akinobu Taketomi
  Journal of Gastroenterology and Hepatology.2019; 34(6): 1074.     CrossRef
• Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score–Matched Study
  Yu-Hui Huang, Benjamin V. Park, Yi-Fan Chen, Ron C. Gaba, Grace Guzman, R. Peter Lokken
  Journal of Vascular and Interventional Radiology.2019; 30(9): 1317.     CrossRef
• Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
  Satoshi Kobayashi, Takeshi Terashima, Satoshi Shiba, Yukio Yoshida, Ikuhiro Yamada, Shouta Iwadou, Shigeru Horiguchi, Hideaki Takahashi, Eiichiro Suzuki, Michihisa Moriguchi, Kunihiro Tsuji, Taiga Otsuka, Akinori Asagi, Yasushi Kojima, Ryoji Takada, Chigu
  Cancer Science.2018; 109(8): 2549.     CrossRef
• Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma
  Lauren S. Chan, Daniel Y. Sze, George A. Poultsides, John D. Louie, Mohammed A. Abdelrazek Mohammed, David S. Wang
  CardioVascular and Interventional Radiology.2017; 40(9): 1383.     CrossRef
• A Case of Curative Resection of Advanced Combined Hepatocellular-cholangiocarcinoma after Neoadjuvant Chemotherapy
  Jee Eun Choi, Kyung Hee Kim, Seon A Kim, Jung Hwan Lee, Sang Myung Woo, Sang-Jae Park, Eun Kyung Hong, Woo Jin Lee
  Korean Journal of Pancreas and Biliary Tract.2016; 21(2): 101.     CrossRef
• Combined hepatocellular cholangiocarcinoma: Controversies to be addressed
  An-Qiang Wang
  World Journal of Gastroenterology.2016; 22(18): 4459.     CrossRef
• Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy
  Kathryn Fowler, Nael E. Saad, Elizabeth Brunt, M. B. Majella Doyle, Manik Amin, Neeta Vachharajani, Benjamin Tan, William C. Chapman
  Annals of Surgical Oncology.2015; 22(13): 4130.     CrossRef
• Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity
  Kate O’Connor, Joanna C. Walsh, David F. Schaeffer
  Annals of Hepatology.2014; 13(3): 317.     CrossRef
• Transplantation versus resection for patients with combined hepatocellular carcinoma–cholangiocarcinoma
  Ryan T. Groeschl, Kiran K. Turaga, T. Clark Gamblin
  Journal of Surgical Oncology.2013; 107(6): 608.     CrossRef

Citations

Citations to this article as recorded by  

• Metachronous or Synchronous Presentation of Acute Myeloid Leukemia and Lung Cancer: A Single Center Experience
  Başak Ünver Koluman, Atike Gökçen Demiray, Gulsum Akgun Cagliyan, Sibel Hacıoğlu, Nil Güler, Taner Durak, Yeliz Karakaya, Ferda Bir
  Akdeniz Medical Journal.2024;[Epub]     CrossRef
• A Disguising Fast-Growing Metachronous Melanoma and COVID-19
  Alina Avram, Lucian G Scurtu, Mariana Costache, Olga Simionescu
  Cureus.2023;[Epub]     CrossRef
• Solitary solutions to a metastasis model represented by two systems of coupled Riccati equations
  I. Timofejeva, T. Telksnys, Z. Navickas, R. Marcinkevicius, R. Mickevicius, M. Ragulskis
  Journal of King Saud University - Science.2023; 35(5): 102682.     CrossRef
• Triple synchronous malignancies of the stomach, bladder and thyroid in a previously treated prostate cancer patient: A Case Report
  Oliver Oey, Siaw Sze Tiong, Sze Ling Wong, Suresh Navadgi, Yasir Khan
  Folia Medica.2023; 65(4): 693.     CrossRef
• Features of synchronous and metachronous dual primary gastric and colorectal cancer
  Yi-Jia Lin, Hua-Xian Chen, Feng-Xiang Zhang, Xian-Sheng Hu, Hai-Juan Huang, Jian-Hua Lu, Ye-Zi Cheng, Jun-Sheng Peng, Lei Lian
  World Journal of Gastrointestinal Oncology.2023; 15(11): 1864.     CrossRef
• Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
  Tiuri E. Kroese, Richard van Hillegersberg, Sebastian Schoppmann, Pieter R.A.J. Deseyne, Philippe Nafteux, Radka Obermannova, Marianne Nordsmark, Per Pfeiffer, Maria A. Hawkins, Elizabeth Smyth, Sheraz Markar, George B. Hanna, Edward Cheong, Asif Chaudry,
  European Journal of Cancer.2022; 164: 18.     CrossRef
• Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
  Tiuri E. Kroese, Nikita K.N. Jorritsma, Hanneke W.M. van Laarhoven, Rob H.A. Verhoeven, Stella Mook, Nadia Haj Mohammad, Jelle P. Ruurda, Peter S.N. van Rossum, Richard van Hillegersberg
  Clinical and Translational Radiation Oncology.2022; 37: 109.     CrossRef
• Simultaneous triple primary malignancies, including bladder cancer, lymphoma, and lung cancer, in an elderly male: A case report
  Risheng Huang, Zhijia Li, Shanshan Weng, Shenghao Wu
  Open Life Sciences.2022; 17(1): 1263.     CrossRef
• A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect
  Marta Pina, Rute Fernandes, Diogo Fonseca, Cristina Oliveira, Ana Rodrigues
  Cureus.2022;[Epub]     CrossRef
• Management of patients with synchronous head-and-neck and lung cancers
  Nicolas Paleiron, Radj Gervais, Gaelle Rousseau-Bussac, Laurence Bigay Game, Anne Marie Chiappa, Regine Lamy, Florian Guisier, Hervé Le Caer, Gilles Robinet, Acya Bizieux, Christos Chouaïd
  Journal of Cancer Research and Therapeutics.2022; 18(Suppl 2): S160.     CrossRef
• Multiple primary malignancies involving lung cancer: a single-center experience
  Luigi Ventura, Paolo Carbognani, Letizia Gnetti, Maurizio Rossi, Marcello Tiseo, Enrico Maria Silini, Nicola Sverzellati, Mario Silva, Marcello Succi, Cesare Braggio, Sara Cattadori, Giovanni Bocchialini, Valeria Balestra, Michele Rusca, Luca Ampollini
  Tumori Journal.2021; 107(3): 196.     CrossRef
• A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma
  Matthew I Ebia, Stephen Capone, Charité Ricker, Jacob S Thomas, Varsha Tulpule, Irene Kang, Anishka D'Souza, David R Freyer, Kimberly Miller, Gino K In
  Cureus.2021;[Epub]     CrossRef
• A Rare Case of Synchronous Esophageal and Pancreatic Malignancy
  Ali Khalifa, Arkady Broder
  Cureus.2021;[Epub]     CrossRef
• Efficacy and Safety of Local Radiotherapy to All Oligometastatic Sites in Elderly Patients with Metachronous Oligometastatic Cancers After Initial Treatment for the Primary Tumor
  Xiaolong Hu, Hongqi Li, Xiaoli Kang, Xuan Wang, Haifeng Pang, Chen Liu, Jianchun Zhang, Yingjie Wang
  Cancer Management and Research.2021; Volume 13: 9247.     CrossRef
• Synergistic Effect of Lymphatic Invasion and Venous Invasion on the Risk of Lymph Node Metastasis in Patients with Non-Curative Endoscopic Resection of Early Gastric Cancer
  Hye Jin Kang, Hyunsoo Chung, Sang Gyun Kim, Jung Kim, Jue Lie Kim, Eunwoo Lee, Hyun Chae Jung
  Journal of Gastrointestinal Surgery.2020; 24(7): 1499.     CrossRef
• Clear cell renal carcinoma synchronous with dedifferentiated liposarcoma: a case report and review of the literature
  Estefania Beltran, Juan Esteban Garcia-Robledo, Lisa X. Rodríguez-Rojas, Martin Rengifo, Bladimir Perez, Harry Pachajoa, Angela R. Zambrano
  Journal of Medical Case Reports.2020;[Epub]     CrossRef
• Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
  Matthias Guckenberger, Yolande Lievens, Angelique B Bouma, Laurence Collette, Andre Dekker, Nandita M deSouza, Anne-Marie C Dingemans, Beatrice Fournier, Coen Hurkmans, Frédéric E Lecouvet, Icro Meattini, Alejandra Méndez Romero, Umberto Ricardi, Nicola S
  The Lancet Oncology.2020; 21(1): e18.     CrossRef
• Rare heterochronous liver and pancreatic multiple primary cancers: a case report and literature review
  Wangjun Zhang, Fan Xiao, Jie Li, Xiaoyu Guo, Zhitao Lin, Zijian Huang, Ning Mao, Bei Sun, Gang Wang
  Zeitschrift für Gastroenterologie.2020; 58(11): 1094.     CrossRef
• Gastric carcinoma and renal cell carcinoma as an atypical presentation of multiple primary malignancies: a case report and review of the literature
  J. A. Martín-Pérez, C. Torres-Silva, R. Tenorio-Arguelles, D. A. García-Corona, S. Silva-González, J. A. Dominguez-Rodriguez, I. De Alba-Cruz, J. F. Nagore-Ancona, J. A. González-Luna, K. A. López-Bochm
  Journal of Medical Case Reports.2020;[Epub]     CrossRef
• Helicobacter pylori Eradication for Metachronous Gastric Cancer: An Unsuitable Methodology Impeding Broader Clinical Usage
  Alexios-Fotios A. Mentis, Efthimios Dardiotis
  Frontiers in Oncology.2019;[Epub]     CrossRef
• A case report of cholangiocarcinoma combined with moderately differentiated gastric adenocarcinoma
  Yan-Hui Yang, Qing Deng, Tian-Bao Yang, Yang Gui, Yu-xiang Zhang, Jiang-Bo Liu, Qian Deng, Wei-Feng Liu, Jun-Jun Sun
  Medicine.2019; 98(30): e16332.     CrossRef
• Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries
  Asta Agasarova, Clare Harnett, Niall Mulligan, Muhammad Shakeel Majeed, Alberto Caimo, Gianluca Tamagno
  International Journal of Endocrinology.2018; 2018: 1.     CrossRef
• Clinicopathologic characteristics and survival rate in patients with synchronous or metachronous double primary colorectal and gastric cancer
  Ji-Hyeon Park, Jeong-Heum Baek, Jun-Young Yang, Won-Suk Lee, Woon-Kee Lee
  Korean Journal of Clinical Oncology.2018; 14(2): 83.     CrossRef
• Synchronous primary of periampullary and lung cancer: A case report and review of literature
  Vikas Talreja, Vanita Noronha, Amit Joshi, Vijay Patil, Kumar Prabhash
  Cancer Research, Statistics, and Treatment.2018; 1(2): 173.     CrossRef
• Synchronous occurrence of hereditary gastric adenocarcinoma, gastrointestinal stromal tumor, and esophageal small cell and squamous carcinoma in situ: an extremely rare case report
  Huijie Fan, Pei Lu, Li Xu, Yanru Qin, Jing Li
  BMC Cancer.2017;[Epub]     CrossRef
• Multiple primary malignancies involving lung cancer
  Feng Li, Wen-Zhao Zhong, Fei-Yu Niu, Ning Zhao, Jin-Ji Yang, Hong-Hong Yan, Yi-Long Wu
  BMC Cancer.2015;[Epub]     CrossRef
• Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma
  Kenichiro Yabuki, Akira Kubota, Choichi Horiuchi, Takahide Taguchi, Goshi Nishimura, Masahiko Inamori
  European Archives of Oto-Rhino-Laryngology.2013; 270(2): 727.     CrossRef

The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicine. Fifty milligrams of sunitinib was administered intermittently after each hemodialysis session (3 or 4 times a week). Overall responses were partial response in both cases. Progression-free survivals were 16 and 6 months, respectively, at the time of reporting (April 2010). Both subjects tolerated the treatment.

Citations

Citations to this article as recorded by  

• Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
  Elodie Klajer, Louis Garnier, Morgan Goujon, Friederike Schlurmann-Constans, Benoite Mery, Thierry Nguyen Tan Hon, Guillaume Mouillet, Fabien Calcagno, Antoine Thiery-Vuillemin
  Seminars in Oncology.2020; 47(2-3): 103.     CrossRef
• Targeted Agents in Patients with Metastatic Renal Cell Carcinoma on Dialysis: Myths and Reality
  Annalisa Guida, Laura Cosmai, Fabio Gelsomino, Cristina Masini, Roberto Sabbatini, Camillo Porta
  EMJ Nephrology.2016; : 66.     CrossRef
• Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
  Daniele Minardi, Luigi Quaresima, Matteo Santoni, Maristella Bianconi, Mario Scartozzi, Stefano Cascinu, Giovanni Muzzonigro
  Current Urology Reports.2015;[Epub]     CrossRef
• Feasibility, Efficacy and Safety of Tyrosine Kinase Inhibitor Treatment in Hemodialyzed Patients with Renal Cell Cancer: 10 Years of Experience
  Anna M Czarnecka, Maciej Kawecki, Fei Lian, Jan Korniluk, Cezary Szczylik
  Future Oncology.2015; 11(16): 2267.     CrossRef
• Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency
  Ki Hyang Kim, Ho Young Kim, Hye Ryun Kim, Jong-Mu Sun, Ho Yeong Lim, Hyo Jin Lee, Suee Lee, Woo Kyun Bae, Sun Young Rha
  European Journal of Cancer.2014; 50(4): 746.     CrossRef
• Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
  Ibrahim Yildiz, Fatma Sen, Leyla Kilic, Rumeysa Ciftci, Mert Basaran
  Korean Journal of Urology.2014; 55(1): 74.     CrossRef
• A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma
  Ahmed Alasker, Malek Meskawi, Maxine Sun, Salima Ismail, Nawar Hanna, Jens Hansen, Zhe Tian, Marco Bianchi, Paul Perrotte, Pierre I. Karakiewicz
  Cancer Treatment Reviews.2013; 39(4): 388.     CrossRef
• Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey
  Cristina Masini, Roberto Sabbatini, Camillo Porta, Giuseppe Procopio, Giuseppe Di Lorenzo, Azzurra Onofri, Sebastiano Buti, Roberto Iacovelli, Roberta Invernizzi, Luca Moscetti, Maria Giuseppina Aste, Maria Pagano, Federica Grosso, Anna Lucia Manenti, Cin
  BJU International.2012; 110(5): 692.     CrossRef

Citations

Citations to this article as recorded by  

• Duodenal Adenocarcinoma in the Setting of Bariatric Surgery: A Perfect Storm for Wernicke’s Encephalopathy
  Aliza Gross, Allen T Yu, Jacques Lara-Reyna, Koji Park, Eugenius J Harvey
  Cureus.2023;[Epub]     CrossRef
• Thiamine deficiency in pregnancy and lactation: implications and present perspectives
  Ozaifa Kareem, Sobia Nisar, Masood Tanvir, Umar Muzaffer, G. N. Bader
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Beware of lethal Wernicke's encephalopathy after cytoreductive surgery with HIPEC for peritoneal pseudomyxoma: Case report of morbidity and mortality review
  Oumayma Lahnaoui, Nezha EL Bahaoui, Sara El Atiq, Laila Amrani, Mohammed Anass Majbar, Amine Benkabbou, Raouf Mohsine, Amine Souadka
  International Journal of Surgery Case Reports.2022; 98: 107500.     CrossRef
• Thiamine deficiency unrelated to alcohol consumption in high‐income countries: a literature review
  Filomena Gomes, Gilles Bergeron, Megan W. Bourassa, Philip R. Fischer
  Annals of the New York Academy of Sciences.2021; 1498(1): 46.     CrossRef
• WERNICKE ENCEPHALOPATHY IN A PATIENT WITH GASTRIC CANCER RECURRENCE AFTER UPPER GASTROINTESTINAL SURGERY: A CASE REPORT AND REVIEW OF THE LITERATURE
  Zining Liu, Xin Ye, Jiejin Yang, Zeyang Chen
  Gastroenterology Nursing.2020; 43(6): 463.     CrossRef
• Wernicke's encephalopathy in a subject with enter-colic fistula
  Daniele Canova, Paola Scalon, Fabio Monica, Stefano A. Grassi, Anna Giacomin, Tiziana Tumelero, Gaetano Mastropaolo, Francesco Malfa
  Gazzetta Medica Italiana Archivio per le Scienze Mediche.2019;[Epub]     CrossRef
• Wernicke's encephalopathy in a patient with non-Hodgkin's lymphoma post-Autologous HSCT
  João Paulo de Vasconcelos Leitão, Romélia Pinheiro Gonçalves Lemes, Maritza Cavalcante Barbosa, Beatriz Stela Gomes de Souza Pitombeira Araújo, Karine Sampaio Nunes Barroso, Jacques Kaufman, Talyta Ellen de Jesus dos Santos, Anna Thawanny Gadelha Moura, A
  Revista da Associação Médica Brasileira.2018; 64(10): 882.     CrossRef
• Wernicke encephalopathy as initial presentation of lymphoma
  Ju Hyun Seo, Ju Hee Kim, Der Sheng Sun, Hye Sung Won, Jeong Wook Park, Yoon Ho Ko
  The Korean Journal of Internal Medicine.2017; 32(6): 1112.     CrossRef
• The Role of Thiamine and Effects of Deficiency in Dogs and Cats
  Georgia Kritikos, Jacqueline Parr, Adronie Verbrugghe
  Veterinary Sciences.2017; 4(4): 59.     CrossRef
• Association between malignancy and non-alcoholic Wernicke's encephalopathy: a case report and literature review
  Evan Y. Choi, William A. Gomes, Missak Haigentz, Jerome J. Graber
  Neuro-Oncology Practice.2016; 3(3): 196.     CrossRef
• Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  Antonio Macrì, Francesco Fleres, Antonio Ieni, Maurizio Rossitto, Tommaso Mandolfino, Salvatore Micalizzi, Francesco Iaropoli, Carmelo Mazzeo, Massimo Trovato, Eugenio Cucinotta, Edoardo Saladino
  International Journal of Surgery Case Reports.2015; 16: 29.     CrossRef
• Two Cases of Wernicke's Encephalopathy That Developed during Total Parenteral Nutrition in Colon Cancer Patients Treated with 5-Fluorouracil-based Chemotherapy
  Kyung Pyo Cho, Jae Sung Lee, Ji Seok Seong, Yong Moon Woo, Young Jun Cho, Beom Jin Jeong, Jee Hoon Sohn, Su-Jung Kim
  The Korean Journal of Gastroenterology.2014; 64(3): 158.     CrossRef
• Wernicke's encephalopathy in a patient with gastric carcinoma: a diagnosis not to miss
  Chandrashekar Udyavara Kudru, Shivashankara Kaniyoor Nagiri, Sandeep Rao
  BMJ Case Reports.2014; : bcr2013203511.     CrossRef
• Wernicke-Korsakoff Syndrome in Primary Peritoneal Cancer
  Ki Hyang Kim
  Case Reports in Oncology.2013; 6(3): 593.     CrossRef